
TRANS GENIC GROUP INC. — Investor Relations & Filings
TRANS GENIC GROUP INC. is a biotechnology company that operates through two main business segments: Drug Discovery Support and Investment & Consulting. The Drug Discovery Support division provides comprehensive services across the entire drug development pipeline, from basic research to non-clinical and clinical trials. Core services include the contract production of genetically modified animals, particularly mice, using genome editing technologies like CRISPR/Cas9. The company also specializes in contract antibody production, glycosylation analysis, and the supply of model mice. The Investment & Consulting segment focuses on M&A, business succession, and providing advisory and support services for business revitalization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 当社連結子会社による当社孫会社の吸収合併および連結子会社間の吸収合併に関するお知らせ | 2026-05-27 | Japanese | |
| 臨時報告書 | 2026-05-14 | Japanese | |
| 「エクソンヒト化マウス」に関する米国特許査定のお知らせ | 2026-04-22 | Japanese | |
| 確認書 | 2025-11-13 | Japanese | |
| 半期報告書-第28期(2025/04/01-2026/03/31) | 2025-11-13 | Japanese | |
| 訂正確認書 | 2025-08-01 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 47251361 | 当社連結子会社による当社孫会社の吸収合併および連結子会社間の吸収合併に関するお知らせ | 2026-05-27 | Japanese | ||
| 45775927 | 臨時報告書 | 2026-05-14 | Japanese | ||
| 46878231 | 「エクソンヒト化マウス」に関する米国特許査定のお知らせ | 2026-04-22 | Japanese | ||
|
2025
11 filings
| |||||
| 8275048 | 確認書 | 2025-11-13 | Japanese | ||
| 8275033 | 半期報告書-第28期(2025/04/01-2026/03/31) | 2025-11-13 | Japanese | ||
| 7859628 | 訂正確認書 | 2025-08-01 | Japanese | ||
| 7859630 | 訂正有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-08-01 | Japanese | ||
| 7241592 | 訂正臨時報告書 | 2025-07-02 | Japanese | ||
| 7242344 | 臨時報告書 | 2025-07-01 | Japanese | ||
| 7244210 | 確認書 | 2025-06-30 | Japanese | ||
| 7244204 | 内部統制報告書-第27期(2024/04/01-2025/03/31) | 2025-06-30 | Japanese | ||
| 7244201 | 有価証券報告書-第27期(2024/04/01-2025/03/31) | 2025-06-30 | Japanese | ||
| 7259223 | 臨時報告書 | 2025-06-13 | Japanese | ||
| 7266406 | 臨時報告書 | 2025-04-23 | Japanese | ||
|
2024
1 filing
| |||||
| 7298253 | 確認書 | 2024-11-13 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
|
APURES CO., LTD.
Biotech firm providing MICROPIG models, bio-resources, and …
|
149300 | KR | Professional, scientific and te… |
|
Aran Research & Development (1982) Ltd.
A product design and development firm providing services fr…
|
ARAN | IL | Professional, scientific and te… |
|
Arch Biopartners Inc.
Developing novel drugs for acute kidney injury (AKI) and ch…
|
ARCH | CA | Professional, scientific and te… |
|
ARCHER MATERIALS LIMITED
Develops semiconductor devices for quantum computing and me…
|
AXE | AU | Professional, scientific and te… |
|
ARGENICA THERAPEUTICS LIMITED
Clinical-stage developer of neuroprotective drugs for acute…
|
AGN | AU | Professional, scientific and te… |
|
ARIUS Research Inc.
Discovery and development of targeted antibody therapeutics…
|
ARI | CA | Professional, scientific and te… |
|
AROVELLA THERAPEUTICS LIMITED
Develops off-the-shelf iNKT cell therapies for blood cancer…
|
ALA | AU | Professional, scientific and te… |
|
Artiva Biotherapeutics, Inc.
Develops allogeneic, off-the-shelf NK cell therapies for ca…
|
ARTV | US | Professional, scientific and te… |
|
ARVINAS, INC.
Clinical-stage biopharma developing therapeutics based on t…
|
ARVN | US | Professional, scientific and te… |
TRANS GENIC GROUP INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13323/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13323 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13323 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13323 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13323}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TRANS GENIC GROUP INC. (id: 13323)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.